Rate My Professor Alison Blatt

Blatt's research spans basic science, new technologies, and clinical pathways in urology, with a current emphasis on intravesical therapies for benign and malignant bladder conditions. Key projects include evaluating MRI for staging superficial bladder cancer, serving as Principal Site Investigator for the ANZUP 1301 trial comparing BCG with or without Mitomycin for bladder cancer, developing prehabilitation programs for major urological surgery, and participating in the Australasian Pelvic Floor Procedure Registry for incontinence outcomes. Her contributions have earned awards such as the Christopher Farrell Award (2003, USANZ NSW Best Registrar Research), Keith Kirkland Prize and Storz Travelling Fellowship (2005, USANZ Best Research by Urology Trainee), John Lowenthal Society Medal (2009), and RACS Foundation Research Scholarship (2007). Notable publications include 'Causes of delayed exploration of the acute scrotum in a regional paediatric centre' (2021), 'Does the introduction of pre-operative cardiopulmonary exercise testing alter surgical decision making?' (2021), and 'Tumour innervation and neurosignalling in prostate cancer' (2020). An affiliate of the Hunter Medical Research Institute, she serves on the board of the Alport Foundation of Australia and holds memberships in the Urological Society of Australia and New Zealand, European Association of Urology, and International Continence Society.